What's new

Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 14, Status: Authorised

Feb 17, 2025 - 17:21
 0
Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

EMEA-002713-PIP02-21-M01

Next Article

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Va...

Related Posts

Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Date of authorisation: 13/02/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive

Orphan designation: Allogenic umbilical cord-derived os...

Feb 20, 2025  0

EMEA-003063-PIP02-22

EMEA-003063-PIP02-22

Feb 26, 2025  0